1. Home
  2. MAIA vs NTZ Comparison

MAIA vs NTZ Comparison

Compare MAIA & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • NTZ
  • Stock Information
  • Founded
  • MAIA 2018
  • NTZ 1959
  • Country
  • MAIA United States
  • NTZ Italy
  • Employees
  • MAIA N/A
  • NTZ N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • MAIA Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • MAIA 46.7M
  • NTZ 39.0M
  • IPO Year
  • MAIA 2022
  • NTZ 1993
  • Fundamental
  • Price
  • MAIA $1.74
  • NTZ $3.64
  • Analyst Decision
  • MAIA
  • NTZ
  • Analyst Count
  • MAIA 0
  • NTZ 0
  • Target Price
  • MAIA N/A
  • NTZ N/A
  • AVG Volume (30 Days)
  • MAIA 417.6K
  • NTZ 2.1K
  • Earning Date
  • MAIA 08-08-2025
  • NTZ 07-07-2025
  • Dividend Yield
  • MAIA N/A
  • NTZ N/A
  • EPS Growth
  • MAIA N/A
  • NTZ N/A
  • EPS
  • MAIA N/A
  • NTZ N/A
  • Revenue
  • MAIA N/A
  • NTZ $330,051,765.00
  • Revenue This Year
  • MAIA N/A
  • NTZ N/A
  • Revenue Next Year
  • MAIA N/A
  • NTZ N/A
  • P/E Ratio
  • MAIA N/A
  • NTZ N/A
  • Revenue Growth
  • MAIA N/A
  • NTZ N/A
  • 52 Week Low
  • MAIA $1.40
  • NTZ $3.07
  • 52 Week High
  • MAIA $4.24
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 47.75
  • NTZ 45.46
  • Support Level
  • MAIA $1.66
  • NTZ $3.25
  • Resistance Level
  • MAIA $1.95
  • NTZ $4.40
  • Average True Range (ATR)
  • MAIA 0.12
  • NTZ 0.08
  • MACD
  • MAIA -0.00
  • NTZ -0.03
  • Stochastic Oscillator
  • MAIA 31.82
  • NTZ 33.91

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: